Home » Newsletters » BioWorld Asia

BioWorld Asia

Feb. 25, 1998

View Archived Issues

Lilly To Pay Xenova $35M For Heart Attack Drug

Gene Found That Keeps Female Embryos Female

Genset's Revenues Double; But R&D Spending Widens '97 Loss

Canadian Biotech Groups Merge To Form National Body

Appligène Oncor Reports Disappointing '97 Results

Foiled By Nonviral Vectors, Therexsys Shifts Gene Therapy

Cerep's IPO On Nouveau Marché Raises FFr67.5M

Germany Backs China's Biotech International Exhibition

EU Advisory Panel On Ethics Formed With Lenoir As Chairman

Amrad Acquires Diagnostic Firm For A$50M In Cash, Stock

HIV Drug Developer Frustrated; Pursuing Studies In China

Peptech Making Changes; Returning To Australia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...